These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The effect of the calcium antagonist nimodipine on the gerbil model of experimental cerebral ischemia. Fujisawa A; Matsumoto M; Matsuyama T; Ueda H; Wanaka A; Yoneda S; Kimura K; Kamada T Stroke; 1986; 17(4):748-52. PubMed ID: 3738960 [TBL] [Abstract][Full Text] [Related]
26. [The effect of clinical trials on hospital admission for stroke]. Vila N; Chamorro A Rev Neurol; 1997 Jul; 25(143):1129-31. PubMed ID: 9280654 [TBL] [Abstract][Full Text] [Related]
27. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview. Grupke S; Hall J; Dobbs M; Bix GJ; Fraser JF Clin Neurol Neurosurg; 2015 Feb; 129():1-9. PubMed ID: 25497127 [TBL] [Abstract][Full Text] [Related]
29. Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research. Reis C; Akyol O; Ho WM; Araujo C; Huang L; Applegate R; Zhang JH Biomed Res Int; 2017; 2017():4863079. PubMed ID: 28286764 [TBL] [Abstract][Full Text] [Related]
30. [Intravenous tissue-type plasminogen activator for the treatment of acute cerebral ischemia]. Dávalos A; Alvarez-Sabín J; Martí-Vilalta JL; Castillo J; Med Clin (Barc); 2003 Jan; 120(1):1-5. PubMed ID: 12525296 [TBL] [Abstract][Full Text] [Related]
39. The penumbra, therapeutic time window and acute ischaemic stroke. Fisher M; Takano K Baillieres Clin Neurol; 1995 Aug; 4(2):279-95. PubMed ID: 7496621 [TBL] [Abstract][Full Text] [Related]
40. Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. Rahme R; Yeatts SD; Abruzzo TA; Jimenez L; Fan L; Tomsick TA; Ringer AJ; Furlan AJ; Broderick JP; Khatri P J Neurosurg; 2014 Dec; 121(6):1354-8. PubMed ID: 25259569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]